Eli Lilly and Company Revenue 2020–2025
Eli Lilly and Company annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Eli Lilly and Company revenue for the quarter ending March 31, 2026 was 19.8 B, a 55.55% increase year-over-year.
- Eli Lilly and Company revenue for the twelve months ending March 31, 2026 was 72.2 B.
- Eli Lilly and Company annual revenue for 2025 was 65.2 B, a 44.70% increase from 2024.
- Eli Lilly and Company annual revenue for 2024 was 45.0 B, a 32.00% increase from 2023.
- Eli Lilly and Company annual revenue for 2023 was 34.1 B, a 19.56% increase from 2022.
- Eli Lilly and Company annual revenue for 2022 was 28.5 B.
Eli Lilly and Company (LLY) — Frequently Asked Questions
Eli Lilly and Company (LLY) is a publicly traded US company in the Healthcare sector. It has a market capitalization of $1.05T. In fiscal 2025 it reported revenue of $65.18B and net income of $20.64B. Explore LLY's stock price, financial statements, earnings history, margins and key ratios below.
What is Eli Lilly and Company's market cap?
Eli Lilly and Company (LLY) has a market capitalization of $1.05T.
What is the LLY stock price?
LLY trades at $1169.31 (+2.90% on the day).
How much revenue does Eli Lilly and Company make?
Eli Lilly and Company reported revenue of $65.18B in fiscal 2025.
Is LLY profitable?
In fiscal 2025, Eli Lilly and Company reported net income of $20.64B.
What is LLY's P/E ratio?
Based on diluted EPS, LLY has a price-to-earnings (P/E) ratio of about 51.0.